chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had Shingles. had the same reaction with the booster/Suspected Vaccination failure; Shingles; Thought I was gonna die; so weak couldn't get in and out of bed; fever 102; pain through my whole body; no appetite; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included impending doom, herpes zoster, weakness, fever, appetite absent and general body pain.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, impending doom, weakness, fever, appetite absent and general body pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the vaccination failure, shingles, impending doom, weakness, fever and general body pain were unknown and the outcome of the appetite absent was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, impending doom, weakness, fever, appetite absent and general body pain to be related to Shingles vaccine. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had shingles not bad at all. The patient got the injection and had the most god awful reactions, the patient thought he/she was gone to die, so weak could not get in and out of the bed, fever of 102, no appetite for 3 days and had same reaction with the booster. For tolerance of 1st dose, refer case US2021AMR179539. The patient had told the physician about the reactions as was told that well that was just the booster so it would not affect you the same way, wrong. The pain through the patient's whole body was unlike anything and he/she had ever experienced, the patient was just saying. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR179539:Same reporter
Swollen right breast; Warm to touch; Tender to the touch; Pink/redness; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 18Mar2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included cholesterol and pollen allergy. Concomitant medications included rosuvastatin calcium (CRESTOR), calcium ascorbate (VITAMIN C), vitamin d nos (VITAMIN D) and multivitamin (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021, the patient experienced swollen right breast, warm to touch, tender to the touch, pink/ redness. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events warm to touch, tender to the touch, pink/ redness and swollen right breast were recovered on an unknown date in Mar2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Apr2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 21-MAY-2015, the patient was vaccinated with improperly stored VARIVAX (Merck) Lot # K020760, expiry date 31-OCT-2016 (dose and route not reported). No adverse event was reported. This case of is one of the two report from the same reporter. Additional information has been requested.
48 hours after adacel vaccination pt began experiencing significant myalgias and arthralgias. Diagnosed with serum sickness on 7/24/08. Treated with prednisone.
Acute large vessel occlusion 3 days post booster vaccine. No other comorbidities.
Hot/cold, cold sweats, dizzy, nauseous, body aches, lethargic, headache, loss of appetite, injection sight pain, lower back and shoulder pain, not thinking clearly, unable to do daily routine  functions.
Heartburn. I?ve only ever had heartburn while pregnant. I?m not currently pregnant.
Gave 10 yo patient injection of FLUZONE and she returned to the waiting area with her mother. She stood up and said she knew she was going to faint because it had happened before on the school bus and while reading. Mother stated that she "was out" for just a few seconds, she did not fall as her mother held her up. No other symptoms reported and she said she felt fine minutes later.
Numbness and tingling in the left lower and upper cheek area by 8/12/2021. By mid-day on  8/16/2021 the left side of the mouth/lips were drooping and there was no elasticity in the muscles on the left side of the face. For example: I could pinch the skin on the left cheek and the skin would stay pinched- it would not go back into place unless I smoothed it down. Likewise I could also push the left lip over and it would ruffle- and stay in that position until I manually moved it back.
numb on nose and chin; numb on lip.; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numb on nose and chin) and HYPOAESTHESIA ORAL (numb on lip.) in a 34-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HYPOAESTHESIA (numb on nose and chin) and HYPOAESTHESIA ORAL (numb on lip.). At the time of the report, HYPOAESTHESIA (numb on nose and chin) and HYPOAESTHESIA ORAL (numb on lip.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment was reported.
Warm To the touch; Itchiness; Red Spot; Swelling; Throbbing; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), VACCINATION SITE WARMTH (Warm To the touch), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Spot) and VACCINATION SITE SWELLING (Swelling) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE, LOSARTAN, VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm To the touch), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red Spot), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Throbbing). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Feb-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. On 03-Mar-2021, VACCINATION SITE WARMTH (Warm To the touch), VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Throbbing) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Red Spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Second dose of vaccine received April 26/ test is positive yesterday; Second dose of vaccine received April 26/ test is positive yesterday; This is a spontaneous report from a contactable consumer (Patient). A 67-year-old female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number: not reported) via an unspecified route of administration on 26Apr2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccination included first dose of BNT162B2 (Solution for injection, Batch/lot number: not reported) on an unknown date. Patient reported that a church member had covid hence decided to have a covid test yesterday. lab test included on covid test: Positive on 27May2021. The outcome of the events was reported as unknown.   Information on the lot/batch number has been requested.
Pt developed hives along L upper and middle arm. Mild itching as well. Hives also appeared on neck and R arm. Developed at 10-20 minutes after vaccination. Pt given Allegra 180mg PO. Recovered fully.
Muscle weakness Balance issues Pins and needles in hands  Pain in hands/  nerve pain Healing speed slowed down over 50% Breathing issues and difficulty Chest tightness Rash beneath injection site and redness / heat / inflammation Pain after ejaculation
The first night I didn't feel good and I was running a low grade fever, and the next day I was running a slight fever. I kept getting worse and by that evening I was very nauseated and vomiting and my fever went up to 103. I just pretty much laid around and drank fluids and just kept taking Advil for the fever. That lasted for a couple of days, and then I started getting better. I did see a doctor and that's when I went up and I was checked and they said I had a sinus infection and they checked and said I had COVID-19 and my COVID-19 symptoms lasted for about four days.
This case was reported by a consumer and described the occurrence of swelling injection site in a 5-year-old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine (Infanrix, GlaxoSmithKline) for prophylaxis. A physician or other health care professional has not verified this report. Previous and/or concurrent vaccination included influenza virus vaccine given on 21 November 2007. On 21 November 2007 at 14:00 the subject received 1st dose of Infanrix (unknown, right arm). On 21 November 2007, 1 hour after vaccination with Infanrix, the subject experienced swelling injection site, injection site pruritus and mark at injection site approximately 2 inches by 1.5  inches. The immunization series was discontinued. The events of swelling injection site and injection site pruritus resolved after three days. The reporter was not certain the vaccine administered was Infanrix. At the time of reporting the mark at injection site was unresolved.
At the end of the conversation, caller stated that recently saw in (place name) that someone passed away 3 hours after receiving the injection.; This is a spontaneous report from a contactable nurse.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date at single dose for COVID-19 immunization.  Medical history and concomitant medication were not reported. Caller, calling on behalf of her sister who has pseudocholinesterase imbalance, would like to know if the Covid vaccine has any contraindication or interaction with succinylcholine. Caller stated that her and her sister are scheduled to receive the first dose of the vaccine this weekend. Caller stated that her sister had a severe reaction to succinylcholine and did not wake up for four days. Caller stated that her sister has to wear a medical bracelet because of this condition. Caller reported that her sister's son has the same severe reaction to succinylcholine. Caller also stated that when she was a director in the lab, she heard of a person passing away in the OR due to the same reaction with succinylcholine. At the end of the conversation, caller stated that recently saw in (state name) that someone passed away 3 hours after receiving the injection. It was unknow if autopsy was done.   Information on the lot/Batch number has been requested.; Sender's Comments: The information currently available does not allow a medically meaningful assessment for the event "passed away" with unknown cause of death.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.; Reported Cause(s) of Death: At the end of the conversation, caller stated that recently saw in (place name) that someone passed away 3 hours after receiving the injection.
day of felt "fuzzy" tired chills/rigors and fever 103, body/aches. 1/7 temp 99 still taking APAP q 3 hrs. nausea. rt axilla swollen and severe pain. 18/ bilateral hand numbness and tingling up to elbow. temp normal, nausea better. no axilla or neck swelling. reports tremors (that aren't visible) when tries to write "feels not right". 1/11 all sxs resolved. ok to work.
This is a spontaneous report received from a contactable reporter  A 74-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Oct2022 at 13:00 as dose 5 (booster), single (Lot number: GJ3277) at the age of 73 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 23Feb2021 at 12:00 as dose 1, single (Lot number: EN6198), on 16Mar2021 at 12:00 as dose 2, single (Lot number: EP6955) and on 03Nov2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 17May2022 at 12:00 as dose 4 (booster), single (Lot number: 037A22B), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "Thyroid nodule" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: 01Sep1992; CALCIUM, start date: 01Feb1999; WELLBUTRIN, start date: 01Feb2001; TRAZODONE, start date: 01Aug2012, stop date: 14Feb2023; FISH OIL, start date: 01Jul2015; VIT D [VITAMIN D NOS], start date: 01Oct2015. 9
tingling  and swelling in face and mouth, tongue peeling, loss of smell and taste, neuromuscular systems  got worse, lost voice for weeks
Swelling, redness upper arm, tingling post vax. Swelling moved to lower arm. Inner forearm swollen, red. Joint aching, pain of movement in elbow. General aching of all joints. Arm dry, flakey, funny color, darker color. Follow up states patient experienced weakness. 1st Varivax given 12/6/99-had one small vesicle-blistered. 1/13/00 client felt stinging sensation in arm. 1/14/00 had appt with her PMD who stated arm was red and swollen. Swelling increased even down to innerside of forearm, cleint c/o joint pain on movement. 2/15+16 experienced joint and general aching through out body; but without aching on movement. 1/20/00-swelling has gone down. Client L arm is dry and feels weird. Has very little feeling to touch on that arm, states swelling ha sgone, no redness, but elbow joint stil tender to touch, but not on movement. 1/21/00 called to verify amt of Benadryl client took on 1/14 +15, took Benadryl q 11. But 1/16-took Benadryl only a few times. Admitte dshe was pretty sleepy at times client concerned about wrinkly ? sluffing off, told to call if further reactions occurred. 1/27/00 no soreness in Lt elbow joint. Skin no longer dry looked healthy. Client stated on 2/14/00 (1 month from raections), woke up aching so she took Ibuprofen-10 tabs in one day-without any effect on the pain. The pain was very severe for 2 1/2 days, until by 2/21/00 only a small amt of pain. Was aching over the entire body. She did not call HD or PMD. Was going to call if not better by 2/22/00. At questioning further, client had severe reaction to bee sting, had to take Epinephrine at approx. 3 yrs.
spot is hot to the touch; arm started to swell / left arm is (swole up) swollen; arm started  red; she's got a fever in it too.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (spot is hot to the touch), PERIPHERAL SWELLING (arm started to swell / left arm is (swole up) swollen), ERYTHEMA (arm started  red) and FEELING HOT (she's got a fever in it too.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced FEELING HOT (spot is hot to the touch), PERIPHERAL SWELLING (arm started to swell / left arm is (swole up) swollen), ERYTHEMA (arm started  red) and FEELING HOT (she's got a fever in it too.). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING HOT (spot is hot to the touch), PERIPHERAL SWELLING (arm started to swell / left arm is (swole up) swollen), ERYTHEMA (arm started  red) and FEELING HOT (she's got a fever in it too.) outcome was unknown.            No concomitant medication was given by reporter.
He was unusually tired the week prior to the more serious symptoms.  He also reported being anxious and restless.  On 9/21 he had a fever of 100, pain in his neck and the dorsum of his left hand.  9/22:  fever of 100.8, frontal headache, severe pain behind both eyes.  9/22 eve:  fever of 103.  Consulted a homeopath, gave pulsatilla 200C every 3 hours.  9/23 fever 100.  9/24: fever normal but still tired.   The severe eye pain was pretty scary.  I can't imagine a nonverbal baby going through that.
@1052 pt c/o numbness and tingling in left arm and it intensified to left leg, right toes, left side of face. @1100 c/o of same numbness in addition to heaviness from the shoulders down and a little dizzy. @1115 pt stated he felt better and stated he felt Narrative: @1052 BP 123/85,Pulse 73, Res 16, SP02 99 RA: pt c/o numbness and tingling in left arm and it intensified to left leg, right toes, left side of face @ 1100 BP 117/78, Pulse 73, Rep 16, SP02 99 RA: c/o of same numbness in addition to heaviness from the shoulders down and a little dizzy. @ 1115 BP 132/77, Pulse 68, Rep 16, SP02 98 RA. pt stated he felt better and stated he felt numbness in left arm and left leg. Offered Benadryl pt declined and stated "he was fine to leave." Pt returned to clinic @1243 BP 137/89, Pulse 71, Rep 16, SP02 98 RA: c/o same tingling but migrated to neck but reported no shortness of breath. 1250: BP 137/89, Pulse 74, Rep 16, SP02 RA: eBenadryl given and code 99 called. Pt transported ED.
Patient developed left leg swelling approximately 48 hours after receiving vaccines. No fever.  Had a 9 cm X 10 cm area of erythema around injection site.  Patient was asked to apply ice for 24 hours on a 3 times a day basis.
COVID Infection; COVID Infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 44-year-old male patient received BNT162b2 (BNT162B2), on 21Mar2021 as dose 1, single (Lot number: EN6208), in left arm, on 02Apr2021 as dose 2, single (Lot number: ER9737), in left arm and on 30Nov2021 as dose 3 (booster), single (Lot number: 320308D) at the age of 44 years, in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 14May2022, outcome "recovered", COVID-19 (medically significant) with onset 14May2022, outcome "recovered" and all described as "COVID Infection". The patient underwent the following laboratory tests and procedures: Polymerase chain reaction: (19May2022) Positive, notes: Nasal Swab; SARS-CoV-2 test: (29May2022) Negative, notes: Other; (16May2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200792657 same patient and drug, different event separated in time.
Significant redness and swelling to injection site.  Tender to touch lasted 3-4 days.  Took MOTRIN for discomfort.
Information has been received from a pharmacist concerning a 50 year old female patient with arthritis and fibromyalgia and a history of drug hypersensitivity who on 14-SEP-2010 was vaccinated with a 0.5 ml dose, intramuscularly of PNEUMOVAX 23 (Lot # 665402/1339Y, Exp date 22-JUN-2011). Concomitant therapy included warfarin. On 14-SEP-2010 the patient experienced red streaks on skin which ran from under the injection side to her arm pit after receiving the vaccine. She also complained of soreness at the injection site. At the time of the report, the patient had no recovered. The patient sought unspecified medical attention. There were no laboratories performed. Additional information has been requested.
slight red rash around the injection site; slightly itchy rash around the injection site; Rash 2 inches in diameter around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (slight red rash around the injection site), VACCINATION SITE PRURITUS (slightly itchy rash around the injection site) and VACCINATION SITE RASH (Rash 2 inches in diameter around the injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (slight red rash around the injection site), VACCINATION SITE PRURITUS (slightly itchy rash around the injection site) and VACCINATION SITE RASH (Rash 2 inches in diameter around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (slight red rash around the injection site), VACCINATION SITE PRURITUS (slightly itchy rash around the injection site) and VACCINATION SITE RASH (Rash 2 inches in diameter around the injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment details included for the symptoms: cortisone cream. Other: Blood thinner and Simvastatin.